Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry

作者: Simon D. Brandt , Sharon A. Moore , Sally Freeman , Abu B. Kanu

DOI: 10.1002/DTA.142

关键词:

摘要: The present study established an impurity profile of a synthetic route to the hallucinogenic N,N-dimethyltryptamine (DMT). synthesis was carried out under reductive amination conditions between tryptamine and aqueous formaldehyde in presence acetic acid followed by reduction with sodium cyanoborohydride. Analytical characterization this gas chromatography ion trap mass spectrometry using electron- chemical-ionization modes. Methanol employed as liquid CI reagent impact stoichiometric modifications on side-products formation also investigated. Tryptamine 1, DMT 2, 2-methyltetrahydro-β-carboline (2-Me-THBC, 3), N-methyl-N-cyanomethyltryptamine (MCMT, 4), N-methyltryptamine (NMT, 5), 2-cyanomethyl-tetrahydro-β-carboline (2-CM-THBC, 6) tetrahydro-β-carboline (THBC, 7) have been detected variety conditions. Replacement solution paraformaldehyde resulted incomplete conversion starting material whereas similar replacement cyanoborohydride borohydride almost exclusively produced THBC instead expected DMT. Compounds 1 7 were quantified limits detection 28.4, 87.7, 21.5, 23.4, 41.1, 36.6, 34.9 ng mL−1, respectively. quantification for compounds 32.4, 88.3, 25.4, 24.6, 41.4, 39.9, 37.0 µg Linearity observed range 20.8–980 mL−1 correlation coefficients > 0.99. application holds great promise area forensic chemistry where development reliable analytical methods detection, identification, are crucial pharmaceutical analysis might be prepared use human clinical studies. Copyright © 2010 John Wiley & Sons, Ltd.

参考文章(44)
G. M. Badger, The chemistry of heterocyclic compounds Academic Press. ,(1961)
Leslie J. Street, Raymond Baker, Jose L. Castro, Mark S. Chambers, Alexander R. Guiblin, Sarah C. Hobbs, Victor G. Matassa, Austin J. Reeve, Margaret S. Beer, Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors Journal of Medicinal Chemistry. ,vol. 36, pp. 1529- 1538 ,(1993) , 10.1021/JM00063A003
Jonathan Ott, Pharmahuasca: human pharmacology of oral DMT plus harmine. Journal of Psychoactive Drugs. ,vol. 31, pp. 171- 177 ,(1999) , 10.1080/02791072.1999.10471741
Alexander T. Shulgin, DMT & TMA-2 Journal of Psychedelic Drugs. ,vol. 8, pp. 167- 169 ,(1976) , 10.1080/02791072.1976.10471846
Stéphane Bouchonnet, Danielle Libong, Michel Sablier, Low pressure chemical ionization in ion trap mass spectrometry. European Journal of Mass Spectrometry. ,vol. 10, pp. 509- 521 ,(2004) , 10.1255/EJMS.649
Rick J. Strassman, Dose-Response Study of N,N-Dimethyltryptamine in Humans Archives of General Psychiatry. ,vol. 51, pp. 85- 97 ,(1994) , 10.1001/ARCHPSYC.1994.03950020009001
K. Heekeren, A. Neukirch, J. Daumann, M. Stoll, M. Obradovic, K.-A. Kovar, M.A. Geyer, E. GouzouLis-Mayfrank, Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis. Journal of Psychopharmacology. ,vol. 21, pp. 312- 320 ,(2007) , 10.1177/0269881107077734
Jose L. Castro, Raymond Baker, Alexander R. Guiblin, Sarah C. Hobbs, Matthew R. Jenkins, Michael G. N. Russell, Margaret S. Beer, Josephine A. Stanton, Kate Scholey, Synthesis and biological activity of 3-[2-(dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin- 2-yl)-methyl]-1H-indole and analogues: agonists for the 5-HT1D receptor. Journal of Medicinal Chemistry. ,vol. 37, pp. 3023- 3032 ,(1994) , 10.1021/JM00045A006